Abstract:Lipoteichoic acid (LTA) plays an essential role in bacterial growth and resistance to antibiotics, and LTA synthetase (LtaS) was considered as an attractive target for combating Gram-positive infections. Azalomycin F, a natural guanidyl-containing polyhydroxy macrolide, can target the LTA of Staphylococcus aureus. Using various technologies including enzyme-linked immunosorbent assay, transmission electron microscope, proteomics, and parallel reaction monitoring, here, the experimental results indicated that azalomycin F can accelerate the LTA release and disrupt the cell envelope, which would also lead to the feedback upregulation on the expressions of LtaS and other related enzymes. Simultaneously, the reconstituted enzyme activity evaluations showed that azalomycin F can significantly inhibit the extracellular catalytic domain of LtaS (eLtaS), while this was vague for LtaS embedded in the liposomes. Subsequently, the fluorescence analyses for five incubation systems containing azalomycin F and eLtaS or the LtaS-embedded liposome indicated that azalomcyin F can spontaneously bind to the active center of LtaS. Combining the mass spectroscopy analyses and the molecular dockings, the results further indicated that this interaction involves the binding sites of substrates and the LTA prolongation, especially the residues Lys299, Phe353, Trp354 and His416. All these suggested that azalomycin F has multiple antibacterial mechanisms against S. aureus. It can not only inhibit LTA biosynthesis through the interactions of its guanidyl side chain with the active center of LtaS but also disrupt the cell envelope through the synergistic effect of accelerating the LTA release, damaging the cell membrane, and electrostatically interacting with LTA. Simultaneously, these antibacterial mechanisms exhibit a synergistic inhibition effect on S. aureus cells, which would eventually cause the cellular autolysis.

Antibacterial activity and mechanism of new acetylated ligorhamnosides

Antibiotic mechanism of novel oligorhamnoside derivatives(dirhamnoside derivative compound 7 and cleistrioside-5)targeting the cell wall

Antimicrobial Mechanism of Novel Oligorhamnoside Derivatives of Dirhamnoside Derivative Compound 7 and Cleistrioside-5 Against Gram-positive Cocci

Synthesis and in vitro Antibacterial Activities of Some Bis-Oxazolidinones

Synthesis and Antibacterial Evaluation of a Series of Oligorhamnoside Derivatives.

Antibacterial, partially acetylated oligorhamnosides from Cleistopholis patens.

Design, Synthesis and Biological Evaluation of Lophanic Acid Derivatives as Antifungal and Antibacterial Agents

The antibacterial activity and structure-activity relationship of lactivicin derivatives

Streptoindoles A–D, Novel Antimicrobial Indole Alkaloids from the Marine-Associated Actinomycete Streptomyces Sp. ZZ1118

The study of 9,10-dihydroacridine derivatives as a new and effective molecular scaffold for antibacterial agent development

Selective Synthesis of Glycoside Fatty Acid Esters and Their Antibacterial Structure‐activity Relationship Against Bacterial Staphylococcus Aureus and Salmonella Agona

The relationship between structural parameters and antibacterial biofilm activity for alkyl rhamnoside as a novel amphiphilic material

Development of Membrane-Active Honokiol/Magnolol Amphiphiles as Potent Antibacterial Agents against Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA)

Antibacterial activity of xanthan-oligosaccharide against Staphylococcus aureus via targeting biofilm and cell membrane

Novel Hydroxamic Acids Containing Aryl-Substituted 1,2,4- or 1,3,4-Oxadiazole Backbones and an Investigation of Their Antibiotic Potentiation Activity

A Novel Antimicrobial Mechanism of Azalomycin F Acting on Lipoteichoic Acid Synthase and Cell Envelope

Promising antibacterials for LLM of Staphylococcus aureus using virtual screening, molecular docking, dynamics, and MMPBSA

Diverse ansamycin derivatives from the marine-derived Streptomyces sp. ZYX-F-97 and their antibacterial activities

Novel natural osthole-inspired amphiphiles as membrane targeting antibacterials against methicillin-resistant Staphylococcus aureus (MRSA)

Chemical Approach for Investigation of the Structure‐Activity Relationship of Salmycin and Identification of a Glycan‐based Analogue for Drug Resistant Staphylococcus aureus

Modification of Biphenolic Anti-Bacterial to Achieve Broad-Spectrum Activity